Covid-19: India begins testing possible cure on patients at PGI Chandigarh
Covid-19: India begins testing possible cure on patients at PGI Chandigarh
India's premier scientific research body announced Covid drug trial.
CSIR-Indian Institute of Integrative Medicine's director spoke on the trials.
Sepsivac, a new drug used against sepsis, being tried on Covid patients.
There are going to be 3 different kinds of trials on various sets of patients.
With the global death toll over 2 lakh, there's a race to create a vaccine or cure.
Watch the video for more.